Authors :
Dr Vishnu Sharma; Vansh Bagrodia
Volume/Issue :
Volume 8 - 2023, Issue 4 - April
Google Scholar :
https://bit.ly/43uxUln
Scribd :
https://bit.ly/3mHAsMx
DOI :
https://doi.org/10.5281/zenodo.7839670
Abstract :
The management of chronic myelogenous
leukemia during pregnancy requires balancing the health
of both mother and fetus.Treatment with
dasatinib was initiated 1 week after delivery on patient’s
request and she went into complete hematologic remission
after 1 month of therapy. We discuss the course of the
disease and various treatment modalities available for
CML during pregnancy.
The management of chronic myelogenous
leukemia during pregnancy requires balancing the health
of both mother and fetus.Treatment with
dasatinib was initiated 1 week after delivery on patient’s
request and she went into complete hematologic remission
after 1 month of therapy. We discuss the course of the
disease and various treatment modalities available for
CML during pregnancy.
